[Adjuvant hormone therapy of primary breast cancer. Review of the literature].
Focan
C
C
Centre Hospitalier Saint-Joseph.
D000568:Amenorrhea / Q000139:chemically induced; D000616:Aminoglutethimide / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D006728:Hormones; D013629:Tamoxifen; D000616:Aminoglutethimide; D007987:Gonadotropin-Releasing Hormone; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Hormonothérapie adjuvante du cancer du sein primitif. Revue de la littérature.